Vulcan ePI FHIR Implementation Guide
0.1.0 - CI Build
Vulcan ePI FHIR Implementation Guide
0.1.0 - CI Build
Vulcan ePI FHIR Implementation Guide - Local Development build (v0.1.0). See the Directory of published versions
| Active as of 2022-09-02 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="Examplesmpc"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This code system http://spor.ema.europa.eu/v1/example-sections-smpc defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td></tr><tr><td style="white-space:nowrap">3<a name="Examplesmpc-3"> </a></td></tr><tr><td style="white-space:nowrap">4<a name="Examplesmpc-4"> </a></td></tr><tr><td style="white-space:nowrap">8<a name="Examplesmpc-8"> </a></td></tr><tr><td style="white-space:nowrap">9<a name="Examplesmpc-9"> </a></td></tr><tr><td style="white-space:nowrap">32<a name="Examplesmpc-32"> </a></td></tr><tr><td style="white-space:nowrap">47<a name="Examplesmpc-47"> </a></td></tr><tr><td style="white-space:nowrap">55<a name="Examplesmpc-55"> </a></td></tr><tr><td style="white-space:nowrap">56<a name="Examplesmpc-56"> </a></td></tr><tr><td style="white-space:nowrap">57<a name="Examplesmpc-57"> </a></td></tr><tr><td style="white-space:nowrap">58<a name="Examplesmpc-58"> </a></td></tr></table><p><b>Additional Language Displays</b></p><table class="codes"><tr><td><b>Code</b></td><td><b>Greek (el)</b></td><td><b>English (English, en)</b></td><td><b>Norwegian (no)</b></td></tr><tr><td>3</td><td>1. ΟΝΟΜΑΣΙΑ ΤΟΥ ΦΑΡΜΑΚΕΥΤΙΚΟΥ ΠΡΟΪΟΝΤΟΣ</td><td></td><td>1. LEGEMIDLETS NAVN</td></tr><tr><td>4</td><td>2. ΠΟΙΟΤΙΚΗ ΚΑΙ ΠΟΣΟΤΙΚΗ ΣΥΝΘΕΣΗ</td><td>2. QUALITATIVE AND QUANTITATIVE COMPOSITION</td><td>2. KVALITATIV OG KVANTITATIV SAMMENSETNING</td></tr><tr><td>8</td><td>3. ΦΑΡΜΑΚΟΤΕΧΝΙΚΗ ΜΟΡΦΗ</td><td>3. PHARMACEUTICAL FORM</td><td>3. LEGEMIDDELFORM</td></tr><tr><td>9</td><td>4. ΚΛΙΝΙΚΕΣ ΠΛΗΡΟΦΟΡΙΕΣ</td><td>4. CLINICAL PARTICULARS</td><td>4. KLINISKE OPPLYSNINGER</td></tr><tr><td>32</td><td>5. ΦΑΡΜΑΚΟΛΟΓΙΚΕΣ ΙΔΙΟΤΗΤΕΣ</td><td>5. PHARMACOLOGICAL PROPERTIES</td><td>5. FARMAKOLOGISKE EGENSKAPER</td></tr><tr><td>47</td><td>6. ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΠΛΗΡΟΦΟΡΙΕΣ</td><td>6. PHARMACEUTICAL PARTICULARS</td><td>6. FARMASØYTISKE OPPLYSNINGER</td></tr><tr><td>55</td><td>7. ΚΑΤΟΧΟΣ ΤΗΣ ΑΔΕΙΑΣ ΚΥΚΛΟΦΟΡΙΑΣ</td><td>7. MARKETING AUTHORISATION HOLDER</td><td>7. INNEHAVER AV MARKEDSFØRINGSTILLATELSEN</td></tr><tr><td>56</td><td>8. ΑΡΙΘΜΟΣ(ΟΙ) ΑΔΕΙΑΣ ΚΥΚΛΟΦΟΡΙΑΣ</td><td>8. MARKETING AUTHORISATION NUMBER(S)</td><td>8. MARKEDSFØRINGSTILLATELSESNUMMER (NUMRE)</td></tr><tr><td>57</td><td>9. ΗΜΕΡΟΜΗΝΙΑ ΠΡΩΤΗΣ ΕΓΚΡΙΣΗΣ/ΑΝΑΝΕΩΣΗΣ ΤΗΣ ΑΔΕΙΑΣ</td><td>9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</td><td>9. DATO FOR FØRSTE MARKEDSFØRINGSTILLATELSE / SISTE FORNYELSE</td></tr><tr><td>58</td><td>10. ΗΜΕΡΟΜΗΝΙΑ ΑΝΑΘΕΩΡΗΣΗΣ ΤΟΥ ΚΕΙΜΕΝΟΥ</td><td>10. DATE OF REVISION OF THE TEXT</td><td>10. OPPDATERINGSDATO</td></tr></table></div>
</text>
<url value="http://spor.ema.europa.eu/v1/example-sections-smpc"/>
<version value="0.1.0"/>
<name value="Examplesmpc"/>
<title value="EMA example-sections-smpc"/>
<status value="active"/>
<date value="2022-09-02T12:45:28+00:00"/>
<contact>
<name value="Gravitate Health Project"/>
<telecom>
<system value="url"/>
<value value="https://www.gravitatehealth.eu/"/>
</telecom>
</contact>
<description value="Placeholder for EMA example-sections smpc"/>
<content value="complete"/>
<count value="10"/>
<concept>
<code value="3"/>
<designation>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="1. NAME OF THE MEDICINAL PRODUCT"/>
</designation>
<designation>
<language value="no"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="1. LEGEMIDLETS NAVN"/>
</designation>
<designation>
<language value="el"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="1. ΟΝΟΜΑΣΙΑ ΤΟΥ ΦΑΡΜΑΚΕΥΤΙΚΟΥ ΠΡΟΪΟΝΤΟΣ"/>
</designation>
</concept>
<concept>
<code value="4"/>
<designation>
<language value="en"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="2. QUALITATIVE AND QUANTITATIVE COMPOSITION"/>
</designation>
<designation>
<language value="no"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="2. KVALITATIV OG KVANTITATIV SAMMENSETNING"/>
</designation>
<designation>
<language value="el"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="2. ΠΟΙΟΤΙΚΗ ΚΑΙ ΠΟΣΟΤΙΚΗ ΣΥΝΘΕΣΗ"/>
</designation>
</concept>
<concept>
<code value="8"/>
<designation>
<language value="en"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="3. PHARMACEUTICAL FORM"/>
</designation>
<designation>
<language value="no"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="3. LEGEMIDDELFORM"/>
</designation>
<designation>
<language value="el"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="3. ΦΑΡΜΑΚΟΤΕΧΝΙΚΗ ΜΟΡΦΗ"/>
</designation>
</concept>
<concept>
<code value="9"/>
<designation>
<language value="en"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="4. CLINICAL PARTICULARS"/>
</designation>
<designation>
<language value="no"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="4. KLINISKE OPPLYSNINGER"/>
</designation>
<designation>
<language value="el"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="4. ΚΛΙΝΙΚΕΣ ΠΛΗΡΟΦΟΡΙΕΣ"/>
</designation>
</concept>
<concept>
<code value="32"/>
<designation>
<language value="en"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="5. PHARMACOLOGICAL PROPERTIES"/>
</designation>
<designation>
<language value="no"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="5. FARMAKOLOGISKE EGENSKAPER"/>
</designation>
<designation>
<language value="el"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="5. ΦΑΡΜΑΚΟΛΟΓΙΚΕΣ ΙΔΙΟΤΗΤΕΣ"/>
</designation>
</concept>
<concept>
<code value="47"/>
<designation>
<language value="en"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="6. PHARMACEUTICAL PARTICULARS"/>
</designation>
<designation>
<language value="no"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="6. FARMASØYTISKE OPPLYSNINGER"/>
</designation>
<designation>
<language value="el"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="6. ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΠΛΗΡΟΦΟΡΙΕΣ"/>
</designation>
</concept>
<concept>
<code value="55"/>
<designation>
<language value="en"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="7. MARKETING AUTHORISATION HOLDER"/>
</designation>
<designation>
<language value="no"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="7. INNEHAVER AV MARKEDSFØRINGSTILLATELSEN"/>
</designation>
<designation>
<language value="el"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="7. ΚΑΤΟΧΟΣ ΤΗΣ ΑΔΕΙΑΣ ΚΥΚΛΟΦΟΡΙΑΣ"/>
</designation>
</concept>
<concept>
<code value="56"/>
<designation>
<language value="en"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="8. MARKETING AUTHORISATION NUMBER(S)"/>
</designation>
<designation>
<language value="no"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="8. MARKEDSFØRINGSTILLATELSESNUMMER (NUMRE)"/>
</designation>
<designation>
<language value="el"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="8. ΑΡΙΘΜΟΣ(ΟΙ) ΑΔΕΙΑΣ ΚΥΚΛΟΦΟΡΙΑΣ"/>
</designation>
</concept>
<concept>
<code value="57"/>
<designation>
<language value="en"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION"/>
</designation>
<designation>
<language value="no"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value
value="9. DATO FOR FØRSTE MARKEDSFØRINGSTILLATELSE / SISTE FORNYELSE"/>
</designation>
<designation>
<language value="el"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="9. ΗΜΕΡΟΜΗΝΙΑ ΠΡΩΤΗΣ ΕΓΚΡΙΣΗΣ/ΑΝΑΝΕΩΣΗΣ ΤΗΣ ΑΔΕΙΑΣ"/>
</designation>
</concept>
<concept>
<code value="58"/>
<designation>
<language value="en"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="10. DATE OF REVISION OF THE TEXT"/>
</designation>
<designation>
<language value="no"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="10. OPPDATERINGSDATO"/>
</designation>
<designation>
<language value="el"/>
<use>
<system value="http://snomed.info/sct"/>
<code value="900000000000003001"/>
</use>
<value value="10. ΗΜΕΡΟΜΗΝΙΑ ΑΝΑΘΕΩΡΗΣΗΣ ΤΟΥ ΚΕΙΜΕΝΟΥ"/>
</designation>
</concept>
</CodeSystem>
IG © 2021+ . Package hl7.fhir.uv.vulcan-epi#0.1.0 based on FHIR 5.0.0-snapshot1. Generated 2022-09-02
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change